Utility of contrast-enhanced harmonic endoscopic ultrasonography for differential diagnosis of malignant from benign lymphadenopathy: a prospective study

Utility of contrast-enhanced harmonic endoscopic ultrasonography for differential diagnosis of malignant from benign lymphadenopathy: a prospective study - Utility of contrast-enhanced harmonic endoscopic ultrasonography for differential diagnosis of malignant from benign lymphadenopathy: a prospective study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000016331

Enrollment

Registered

2015-01-26

Start date

2015-01-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic carcinoma, Biliary carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cases with lymphadenopathy detected by EUS Cases with pancreatobiliary tumors confirmed by the other imag9ng methods. Written informed consent ECOG performance stautus = 0-2

Exclusion criteria

Exclusion criteria: Inapropriate to perform endoscopic ultrasonography Faiulre of other organs (ASA: Grade 3, 4) Inability to obtain informed consent

Design outcomes

Primary

Measure	Time frame
To compare the diagnostic accuracy of standard EUS, color Doppler EUS and CH-EUS in terms of the ability to differentiate malignant nodes from benign nodes.	—

Secondary

Measure	Time frame
To compare the accuracy of CH-EUS and EUS-FNA in terms of N-stage diagnosis	—

Countries

Japan

Contacts

Public ContactMasayuki Kitano

Kinki University Faculty of Medicine Department of Gastroenterology and Hepatology

m-kitano@med.kindai.ac.jp072-366-0221

Outcome results